DCF — PROVIDENCE MEDICAL CENTER
Enterprise Value: $-249.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-249.9M
Enterprise Value
$-77.5M
PV of Cash Flows
$-172.4M
PV of Terminal Value
$-277.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $110.9M | $-16.4M | -15.0% | $-21.1M | $-19.2M |
| Year 2 | $114.2M | $-15.8M | -14.0% | $-20.6M | $-17.0M |
| Year 3 | $117.7M | $-15.1M | -13.0% | $-20.0M | $-15.1M |
| Year 4 | $121.2M | $-14.9M | -12.0% | $-20.0M | $-13.7M |
| Year 5 | $124.8M | $-15.0M | -12.0% | $-20.3M | $-12.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-249.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$107.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.15293432852217326
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5